Signup Crypto ETF Stocks News

Kessler Topaz Meltzer & Check, LLP Class Action Announcement - MU Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Micron Technology, Inc. ( MU ) - Micron Technology ( NASDAQ:MU )

RADNOR, Pa., Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of Florida against Micron Technology, Inc. ( ...

Source: www.benzinga.com
February 20, 2025 | 23:42:00
Category: News

Here's How Much You Would Have Made Owning Corteva Stock In The Last 5 Years - Corteva ( NYSE:CTVA )

Corteva CTVA has outperformed the market over the past 5 years by 3.28% on an annualized basis producing an average annual return of 17.6%. Currently, Corteva has a market capitalization of $43.76 billion.

Source: www.benzinga.com
February 20, 2025 | 23:45:11
Category: News

Teck to Present at the BMO Global Metals, Mining & Critical Minerals Conference February 24, 2025

VANCOUVER, British Columbia, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Teck Resources Limited ( TSX: TECK.A and TECK.B, NYSE: TECK ) ( "Teck" ) President and Chief Executive Officer Jonathan Price, will be presenting at the BMO Global Metals, Mining & Critical Minerals conference on Monday, February ...

Source: www.globenewswire.com
February 20, 2025 | 23:46:00
Category: News

David Ross Appointed Chief Financial Officer of KPC Health

CORONA, Calif., Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- KPC Health is proud to announce the appointment of C. David Ross, MBA, as Chief Financial Officer ( CFO ) . With over 30 years of executive experience in healthcare financial management, Ross brings an extensive track record of strategic ...

Source: www.benzinga.com
February 20, 2025 | 23:46:02
Category: News

ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® ( Epinephrine Nasal Spray ) to National Formularies, Further Expanding Coverage for Patients

Approximately five months after launch, the inclusion of neffy on these three additional formularies has expanded access to half of all patients and caregivers managing Type 1 allergic reactions, bringing the total number of formulary platforms covering neffy to ...

Source: www.globenewswire.com
February 21, 2025 | 00:02:00
Category: News

Franklin Templeton Launches EZPZ ETF for Weighted Bitcoin, Ethereum Exposure

Franklin Templeton's newest crypto product, listed on the Cboe BZX exchange, offers investors both Bitcoin and Ethereum exposure.

Source: decrypt.co
February 21, 2025 | 00:05:26
Category: News

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - EPIX - ESSA Pharma ( NASDAQ:EPIX )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ESSA Pharma Inc. EPIX between December 12, 2023 and October 31, 2024, inclusive ( the "Class Period" ) , of the important March 25, 2025 lead plaintiff ...

Source: www.benzinga.com
February 21, 2025 | 00:25:00
Category: News

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - REGN - Regeneron Pharmaceuticals ( NASDAQ:REGN )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. REGN between November 2, 2023 and October 30, 2024, both dates inclusive ( the "Class Period" ) , of the important March ...

Source: www.benzinga.com
February 21, 2025 | 00:26:14
Category: News

ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIOA - Bioage Labs ( NASDAQ:BIOA )

NEW YORK, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc.

Source: www.benzinga.com
February 21, 2025 | 00:28:56
Category: News

Centerra Gold Announces Quarterly Dividend of C$0.07 per Common Share - Centerra Gold ( NYSE:CGAU )

TORONTO, Feb. 20, 2025 ( GLOBE NEWSWIRE ) -- Centerra Gold Inc. ( "Centerra" or the "Company" ) CG CGAU announced today that its Board of Directors has approved a quarterly dividend of C$0.07 per common share - approximately C$14.7 million or US$10.2 million in aggregate.

Source: www.benzinga.com
February 20, 2025 | 22:02:32
Category: News

© Natavest 2025 - 2026